Anti-Human IFNG Recombinant Antibody(Fontolizumab)
-
产品编号
YR1022
-
别名
科研级 Fontolizumab ( 芳妥珠单抗 ), Anti-IFNG Recombinant Antibody, Research Grade Fontolizumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Fontolizumab ( 芳妥珠单抗 ), Anti-IFNG Recombinant Antibody, Research Grade Fontolizumab |
Catalog Number | YR1022 |
Molecular Name | Fontolizumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 |
Formulation | PBS, pH7.5 |
Background | Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease. A phase II clinical trial investigating the use for rheumatoid arthritis was terminated because the first phase did not meet the endpoint. |
CAS Number | 326859-36-3 |
Application | IF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | IFNG[Homo sapiens] |